• Company Profiles

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe. Cooley has one of the largest global patent groups with 110+ lawyers and patent professionals worldwide. The team has decades of experience assisting clients in the acquisition, protection, enforcement and monetization of patent rights in the US, Europe and in commercially significant markets around the world. Given our deep experience in this area, we understand what creates commercial value in a patent portfolio and are able to anticipate and mitigate risks for our clients. We are regularly called upon to lead IP due diligence surrounding mergers, acquisitions, funding and other transactions. Our team has led 1,000+ investor-side and company-side patent due diligence reviews.


INNITIUS is a Startup from Spain (Spinoff of University of Granada & Andalusian Public Health System) which develops patented medical devices based on Torsional Waves for the diagnosis of conditions associated with tissue consistency changes.
Fine Birth is INNITIUS’ first product.The Clinical goal of the device is to differentiate between false pre-term labor and true labor. It is the accessible, cost efficient, transformative device that can be used at every PTL event, available as an add-on to existing ultrasound-systems and as a standalone handheld device for the diagnosis of false Threatened Preterm Labor events at the point of care.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.